News, videos and information material about Boehringer Ingelheim BioXcellence™

Media & News

Media & News

Learn more about our work in the biopharmaceutical contract manufacturing business by checking out our latest news, videos and information material.

Whitepaper

Learn more about hot topics in the biopharmaceutical contract manufacturing business.

Learn more about hot topics in the biopharmaceutical contract manufacturing business.

Whitepaper

Learn more about our strong experience in perfusion and fully continuous manufacturing of biopharmaceuticals at our site in Fremont, CA.

Whitepaper

The biopharmaceutical contract manufacturing chain of Boehringer Ingelheim includes the aseptic production of various dosage forms of finished drug products in liquid and lyophilized vials or pre-filled syringes.

Whitepaper

Pioneering CMO in China by leading the CMO trial with the authorities and bringing over 30 years of experience to China to better serve patients and the biopharmaceutical industry.

Whitepaper

Boehringer Ingelheim has developed and continuously improved the production process for plasmid DNA.

Whitepaper

Interaction and collaboration with customers when transferring processes from a customer to one of Boehringer Ingelheim´s manufacturing sites.

Whitepaper

A fully automated microbial cultivation platform is established at Boehringer Ingelheim Regional Center Vienna (RCV) to serve the need for scalable high-throughput early-stage microbial bioprocess development.

Case Study

Während biopharmazeutische Prozesse bisher nur durch aufwändige, zeitintensive Analysenmethoden und im Rückblick beurteilt werden konnten, ermöglicht ein neu entwickeltes Verfahren die Kontrolle dieser Prozesse erstmals in Echtzeit.

Research Article

The authors present a model for predicting mixing behavior in a tortuous‐flow‐path reactor. This developed model allows fine‐tuning of flow rate and chamber volume based on process requirements.

Research Article

The authors present an alternative, novel, linked bioreactor process that might serve to reduce manufacturing costs and increase process productivity potentially helping to meet the high projected demands of biologics and competition from biosimilars.

Research Article

Among production cell lines for recombinant biopharmaceuticals, Chinese hamster ovary (CHO) cells are the most commonly used production hosts due to beneficial characteristics such as high productivity, robustness, human‐like post‐translational modifications and ease of genetic modification.

Research Article

The creation of a fully automated microbial cultivation platform for microbial process development that allows “hands‐off” operation without any manual intervention.

Press Releases

Read the latest press releases about Boehringer Ingelheim BioXcellence™

Read the latest press releases about Boehringer Ingelheim BioXcellence™

Videos

Check out the comprehensive collection of videos from Boehringer Ingelheim BioXcellence™.

For further videos, please visit our YouTube channel.

Check out the comprehensive collection of videos from Boehringer Ingelheim BioXcellence™.
For further videos, please visit our YouTube channel.

Biopharmaceuticals - Competence and Experience for Medicines of the Future

Over 35 years ago, Boehringer Ingelheim started developing and producing biopharmaceuticals as one of the first companies worldwide. Biopharmaceuticals are produced by using either mammalian cell cultures or microorganisms such as bacteria or yeast.

Introducing Boehringer Ingelheim BioXcellence™

Boehringer Ingelheim BioXcellence™ offers reliable biopharmaceutical contract development and manufacturing business to the pharmaceutical and biotechnology industry, providing the entire lifecycle chain from DNA to Fill & Finish around the globe.

Producing Value with Boehringer Ingelheim BioXcellence™

Boehringer Ingelheim BioXcellence™ offers over 35 years of biotechnology experience and a global network providing the entire production chain from DNA to Fill & Finish.

World‘s leading and most trusted partner

Boehringer Ingelheim BioXcellence™ is the preferred partner for contract manufacturing of biopharmaceutical medicines through the entire product lifecycle from DNA to Fill & Finish.

Leader in aseptic processing of biopharmaceutical medicines – Liquid Vials

Boehringer Ingelheim BioXcellence™ offers filling services of liquid preparations in vials for clinical or commercial supply. To accommodate your needs, we offer flexible vial and batch sizes from 1,000 to 25,000 units.

Leader in aseptic processing of biopharmaceutical medicines – Freeze-dried Vials

Boehringer Ingelheim BioXcellence™ offers filling services of freeze-dried preparations in vials for clinical or commercial supply. To accommodate your needs, we offer flexible vial and batch sizes from 1,000 to 25,000 units.

Mammalian Manufacturing Plant Shanghai, China

Boehringer Ingelheim is the first multi-national pharmaceutical company bringing over 35 years of experience to China, to better serve the patients and the biopharmaceutical industry.

Transparent production process

Full scale 15,000 L acrylic reactor model enables us to better understand bioreactor behaviour, optimize process parameters and verify numerical flow simulations.

Boehringer Ingelheim BioXcellence™ Site Expansion in Fremont, California

Journey of our significant site expansion of our biopharmaceutical development and manufacturing facility in Fremont, CA, USA.

Boehringer Ingelheim BioXcellence™ on YouTube

Find more Videos on YouTube

For further videos, please visit our YouTube channel.

Information Brochures

Click on the links below to download information material from Boehringer Ingelheim BioXcellence™.

Click on the links below to download information material from Boehringer Ingelheim BioXcellence™.

Learn more about the contract manufacturing business of Boehringer Ingelheim BioXcellence™

Contract manufacuring business of Boehringer Ingelheim BioXcellence™

Boehringer Ingelheim BioXcellence™ offers services from DNA to Fill & Finish, from clinical to commercial supply.

Wherever you are, we are by your side.

From our global network we offer first class biopharmaceutical medicines anywhere in the world.

Facts about our mammalian manufacturing plant in Shanghai, China.

Integrated and powerful contract manufacturing services in Shanghai, China

As the first multi-national pharmaceutical company Boehringer Ingelheim BioXcellence™ established the contract manufacturing business of biopharmaceuticals to in Shanghai.

Fill & Finish services at Boehringer Ingelheim BioXcellence™

Fill & Finish services for vials & syringes

From formulation and filling to visual inspection – with our more than 30 years of experience producing more than 25 million units per year, we tailor our products and services to the needs of our customers.